O'Gray JG, Schalm SW, Williams R: Acute liver failure: redefining the syndromes. Lancet. 1993, 342: 273-10.1016/0140-6736(93)91818-7.
Article
Google Scholar
Lee WM, Squires RH, Nyberg SL, Doo E, Hoofnagle JH: Acute liver failure: summary of a workshop. Hepatology. 2008, 47: 1401-1415. 10.1002/hep.22177.
Article
PubMed Central
PubMed
Google Scholar
Ichai P, Samuel D: Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008, 14: S67-S79. 10.1002/lt.21612.
Article
PubMed
Google Scholar
Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G: Intractable Liver Diseases Study Group of Japan, fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res. 2008, 38: 646-657. 10.1111/j.1872-034X.2008.00322.x.
Article
PubMed
Google Scholar
Tygstrup N, Juhl E: Randomized trial of steroid therapy in acute liver failure. Report from the European Association for the Study of the Liver (EASL). Gut. 1979, 20: 620-623. 10.1136/gut.20.7.620.
Article
Google Scholar
Kumar M, Satapathy S, Monga R, Das K, Hissar S, Pande C, Sharma BC, Sarin SK: A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology. 2007, 45: 97-101. 10.1002/hep.21486.
Article
CAS
PubMed
Google Scholar
Clemmesen JO, Kondrup J, Nielsen LB, Larsen FS, Ott P: Effect of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol. 2001, 96: 1217-1223. 10.1111/j.1572-0241.2001.03706.x.
Article
CAS
PubMed
Google Scholar
Gohda E, Tsubouchi H, Nakayama H, Hirono S, Takahashi K, Hashimoto S, Daikuhara Y: Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Ex Cell Res. 1986, 166: 139-150. 10.1016/0014-4827(86)90514-8.
Article
CAS
Google Scholar
Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikukhara Y: Purification and partial characterization of hepatocyte growth factor from plasma of patients with fulminant hepatic failure. J Clin Invest. 1988, 81: 414-419. 10.1172/JCI113334.
Article
PubMed Central
CAS
PubMed
Google Scholar
Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T, Higashio K, Kurokawa K: Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology. 1993, 18: 1443-1449. 10.1016/0270-9139(93)90237-H.
Article
CAS
PubMed
Google Scholar
Ishii T, Sato M, Sudo K, Suzuki M, Nakai H, Hishida T, Niwa T, Umezu K, Yuasa S: Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem. 1995, 117: 1105-1112.
CAS
PubMed
Google Scholar
Moriuchi A, Hirono S, Ido A, Ochiai T, Nakama T, Uto H, Hori T, Hayashi K, Tsubouchi H: Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes. Biochem Biophys Res Commun. 2001, 280: 368-373. 10.1006/bbrc.2000.4063.
Article
CAS
PubMed
Google Scholar
Hasuike S, Ido A, Uto H, Moriuchi A, Tahara Y, Nagata K, Hori T, Hayashi K, Tsubouchi H: Hepatocyte growth factor accelerates the proliferation and differentiation of hepatic oval cells in a 2-acetylaminofluorene/partial hepatectomy model in rats. J Gastroenterol Hepatol. 2005, 20: 1753-1761. 10.1111/j.1440-1746.2005.03922.x.
Article
CAS
PubMed
Google Scholar
Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS: Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA. 2004, 101: 4477-4482. 10.1073/pnas.0306068101.
Article
PubMed Central
CAS
PubMed
Google Scholar
Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C: Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA. 2004, 101: 10608-10613. 10.1073/pnas.0403412101.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ozaki M, Haga S, Zhang HQ, Irani K, Suzuki S: Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1. Cell Death Differ. 2003, 10: 508-515. 10.1038/sj.cdd.4401172.
Article
CAS
PubMed
Google Scholar
Schulze-Bergkamen H, Brenner D, Krueger A, Suess D, Fas SC, Frey CR, Dax A, Zink d, Buchler P, Muller M, Krammer PH: Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology. 2004, 39: 645-654. 10.1002/hep.20138.
Article
CAS
PubMed
Google Scholar
Moumen A, Ieraci A, Patane S, Sole C, Comella JX, Dono R, Maina F: Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3K-Akt-dependent manner. Hepatology. 2007, 45: 1210-1217. 10.1002/hep.21604.
Article
CAS
PubMed
Google Scholar
Okano J, Shiota G, Kawasaki H: Protective action of hepatocyte growth factor for liver injury caused by D-galactosamine in transgenic mice. Hepatology. 1997, 26: 241-1249. 10.1002/hep.510260136.
Article
Google Scholar
Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T: Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun. 1998, 244: 683-690. 10.1006/bbrc.1998.8293.
Article
CAS
PubMed
Google Scholar
Kosai K, Matsumoto K, Funakoshi H, Nakamura T: Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology. 1999, 30: 51-159. 10.1002/hep.510300102.
Article
Google Scholar
Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawasaki S, Setoguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology. 1991, 13: 1-5. 10.1002/hep.1840130102.
Article
CAS
PubMed
Google Scholar
Ido A, Moriuchi A, Kim IL, Numata M, Nagata-Tsubouchi Y, Hasuike S, Uto H, Tsubouchi H: Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatol Res. 2004, 30: 175-181. 10.1016/j.hepres.2004.09.002.
Article
CAS
PubMed
Google Scholar
Kusumoto K, Ido A, Moriuchi A, Katsura T, Kim IL, Takahama Y, Numata M, Kodama M, Hasuike S, Nagata K, Uto H, Inui K, Tsubouchi H: Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats. Int J Mol Med. 2006, 17: 503-509.
CAS
PubMed
Google Scholar
Strain AJ, Ismail T, Tsubouchi H, Arakaki N, Hishida T, Kitamura N, Daikuhara Y, McMaster P: Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest. 1991, 87: 1853-1857. 10.1172/JCI115207.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, Hori T, Hayashi K, Tsubouchi H: Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther. 2003, 307: 146-151. 10.1124/jpet.103.054106.
Article
CAS
PubMed
Google Scholar
Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, Miyazaki H, Sugihara J, Tomita E, Muro Y, Daikuhara Y, Hashimoto S: Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology. 1989, 9: 875-881. 10.1002/hep.1840090615.
Article
CAS
PubMed
Google Scholar
Tsubouchi H, Kawakami S, Hirono S, Miyazaki H, Kimoto M, Arima T, Sekiyama K, Yoshiba N, Arakaki Y, Daikuhara Y: Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor. Lancet. 1992, 340: 307-10.1016/0140-6736(92)92396-W.
Article
CAS
PubMed
Google Scholar
Eguchi S, Okudaira S, Azuma T, Ohno Y, Fujioka H, Furui J, Tanaka K, Kanematsu T: Changes in liver regenerative factors in a case of living-related liver transplantation. Clin Tlanspl. 1999, 13: 536-544. 10.1034/j.1399-0012.1999.130616.x.
Article
CAS
Google Scholar
Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S: Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Cancer Res. 1995, 55: 3105-3109.
CAS
PubMed
Google Scholar
Tsuzuki N, Miyazawa T, Matsumoto K, Nakamura T, Shima K: Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats. Neurol Res. 2001, 23: 417-424. 10.1179/016164101101198659.
Article
CAS
PubMed
Google Scholar
Sun W, Funakoshi H, Nakamura T: Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci. 2002, 22: 6537-6548.
CAS
PubMed
Google Scholar
Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, Matsumoto K, Nakamura T, Takahashi T, Nukiwa T: Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphogenic study. Am J Respir Crit Care Med. 1997, 156: 1937-1944.
Article
CAS
PubMed
Google Scholar
Ueda H, Sawa Y, Matsumoto K, Kitagawa-Sakakida S, Kawahira Y, Nakamura T, Kaneda Y, Matsuda H: Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. Ann Thorac Surg. 1999, 67: 1726-1731. 10.1016/S0003-4975(99)00279-9.
Article
CAS
PubMed
Google Scholar
Miyagawa S, Sawa Y, Taketani S, Kawaguchi N, Nakamura T, Matsuura N, Matsuda H: Myocardial regeneration therapy for heart failure: hepatycte growth factor enhances the effect of cellular cardiomyoplasty. Circulation. 2002, 105: 2556-2561. 10.1161/01.CIR.0000016722.37138.F2.
Article
CAS
PubMed
Google Scholar
Morishita R, Nakamura S, Hayashi S, Taniyama Y, Moriguchi A, Nagano T, Taiji M, Noguchi H, Takeshita S, Matsumoto K, Nakamura T, Higaki J, Ogihara T: Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension. 1999, 33: 1379-1384.
Article
CAS
PubMed
Google Scholar
Numata M, Ido A, Moriuchi A, Kim IL, Tahara Y, Yamamoto S, Hasuike S, Nagata K, Miyata Y, Uto H, Tsubouchi H: Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Inflamm Bowel Dis. 2005, 11: 551-518. 10.1097/01.MIB.0000164192.71381.5c.
Article
PubMed
Google Scholar
Kawaida K, Matsumoto K, Shimazu H, Nakamura T: Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994, 91: 4357-4361. 10.1073/pnas.91.10.4357.
Article
PubMed Central
CAS
PubMed
Google Scholar
Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J, Sawa Y, Matsuda H, Kaneda Y, Ogihara T: Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension. 2004, 44: 203-209. 10.1161/01.HYP.0000136394.08900.ed.
Article
CAS
PubMed
Google Scholar